Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What is the current market size of the dementia treatment industry, and what growth rate is it expected to achieve?
The dementia treatment market size has grown strongly in recent years. It will grow from $18.32 billion in 2024 to $20.14 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to aging population, improved diagnosis rates, rising awareness, expansion of healthcare infrastructure, increasing funding from governments for dementia research and treatment.
The dementia treatment market size is expected to see strong growth in the next few years. It will grow to $29.12 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing healthcare expenditure, higher prevalence of chronic diseases, increasing clinical trials, growth of the pharmaceutical industry, and rising rates of alzheimer’s disease. Major trends in the forecast period include scientific research advancements, use of artificial intelligence and machine learning for diagnosis and treatment management, development of new drugs and therapies, investment in biotechnology, and advances in personalized treatment plans.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24200&type=smp
What are the major drivers contributing to the growth of the dementia treatment market?
The growing prevalence of neurodegenerative disorders is projected to drive the growth of the dementia treatment market in the coming years. Neurodegenerative disorders are conditions marked by the gradual degeneration and loss of nerve cells, leading to progressive impairments in movement, cognition, or both. The rise in neurodegenerative disorders is largely driven by the aging population, as longer life expectancy increases the risk of developing age-related conditions such as Alzheimer’s and Parkinson’s disease, with age being the most significant contributing factor. Understanding neurodegenerative disorders enhances dementia treatment by enabling more precise diagnoses and targeted therapies, as recognizing the specific underlying condition allows for a more personalized and effective approach to managing symptoms. For instance, in April 2024, according to a report published by the Alzheimer’s Association, a US-based non-profit health organization, approximately 6.9 million Americans aged 65 and older were affected by Alzheimer’s dementia, and this figure is projected to double to 13.8 million by 2060. Therefore, the growing prevalence of neurodegenerative disorders will boost the growth of the dementia treatment market.
What are the major market segments driving the growth of the dementia treatment industry?
The dementia treatment market covered in this report is segmented –
1) By Treatment Type: Antipsychotics, Cholinesterase Inhibitors, Memantine, Other Treatment Types
2) By Indication: Alzheimer’s Disease Dementia, Vascular Dementia, Lewy Body Dementia, Frontotemporal Dementia, Parkinson Disease Dementia, Other Indications
3) By Route of Administration: Oral, Transdermal Patch, Injectable
4) By Stage of Dementia: Mild Dementia, Moderate Dementia, Severe Dementia
5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Antipsychotics: Atypical Antipsychotics, Typical Antipsychotics
2) By Cholinesterase Inhibitors: Donepezil, Rivastigmine, Galantamine
3) By Memantine: Memantine Monotherapy, Memantine Combination Therapy
4) By Other Treatment Types: Cognitive Enhancers, NMDA Receptor Antagonists, Nutritional And Herbal Supplements, Hormonal Treatments, Stem Cell Therapy
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/dementia-treatment-global-market-report
What are the key trends shaping the dementia treatment market in the forecast period?
Major companies operating in the dementia treatment market are focusing on developing technologically advanced solutions, such as virtual reality (VR) training programs, to simulate complex and diverse scenarios. Virtual reality training programs are immersive, computer-generated simulations that allow individuals to practice and develop skills in a controlled, interactive, and realistic virtual environment. For instance, in September 2024, Otsuka Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, partnered with Jolly Good Inc., a Japan-based medical technology company, to launch FACEDUO, a virtual reality training program for dementia care. This interactive VR tool, guided by medical experts, helps caregivers, including family members, understand the emotions and behaviors of people with dementia. Simulating real-life scenarios enables caregivers to better respond to the unique needs of dementia patients. The program aims to improve caregiving skills and empathy for more effective support.
Who are the key market players contributing to the growth of the dementia treatment industry?
Major companies operating in the dementia treatment market are Roche Holding AG, AbbVie Inc., Sanofi S.A., Eli Lilly and Company, Amgen Inc., Biogen Inc., Eisai Co. Ltd., Merz Pharmaceuticals GmbH, Acadia Pharmaceuticals Inc., Intra-Cellular Therapies Inc., Cerevance Inc., Retro Biosciences Inc., AviadoBio Ltd., MapHabit Inc., Neuvivo Inc., Harmonic Health Inc., Rippl Care Inc., Isaac Health Inc., EmTech Care Labs Inc., LifeBio Inc.
Which regions are leading the growth of the dementia treatment market globally?
North America was the largest region in the dementia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dementia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Dementia Treatment Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24200&type=smp
Need Customized Data On Dementia Treatment Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24200&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
